Mateja Janković Makek

University Hospital Centre Zagreb — Croatia

Medicine · Health Sciences

21h-index2.3kcitations125works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mycobacterium research and diagnosis(33), Tuberculosis Research and Epidemiology(30), Pneumonia and Respiratory Infections(10), Infectious Diseases and Mycology(9), Chronic Obstructive Pulmonary Disease (COPD) Research(7)

Publications125 total

Factors affecting inflammatory markers in neutropenic patients with bacteremia: An international ID-IRI study
Microbes and Infectious Diseases /Microbes and Infectious Diseases·2025Open Access
Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease
European Respiratory Journal·2025· 1 cited
A multinational Delphi consensus on tuberculosis screening of migrants in Europe
ERJ Open Research·2025Open Access
Treatment and clinical course of lymphangioleiomyomatosis – single center experience
2025
Long-term survival in idiopathic versus connective tissue disease-associated pulmonary hypertension; Croatian registry data
2025
Yield of testing for nontuberculous mycobacteria in patients with obstructive lung diseases and/or lung malignancy in Croatia
2025
Management of Nontuberculous Mycobacterial Pulmonary Disease Refractory to Guideline-Based Therapy: A Systematic Review
2025· 1 citedOpen Access
Frequency and relevance of nontuberculous mycobacterial isolates in patients with COPD exacerbations
2024
Non-cystic fibrosis bronchiectasis (NCFB) in Croatia: data from the European multicenter bronchiectasis audit and research collaboration (EMBARC) registry
2024
Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study
Transplantation·2024· 6 cited
Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI study
Heliyon·2024· 3 citedOpen Access
New priorities for Croatia to pursue tuberculosis pre-elimination
European Respiratory Journal·2024· 3 cited
Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts
ERJ Open Research·2024· 2 citedOpen Access
Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis—An ESGMYC collaborative study
PLoS ONE·2024· 1 citedOpen Access
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
European Respiratory Journal·2024· 30 citedOpen Access
Successful pleurodesis of refractory pleural effusion caused by he-art failure due to restrictive cardiomyopathy caused by amyloidosis
Liječnički vjesnik·2024Open Access
Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID‐19‐associated candidemia
Mycoses·2024· 7 citedOpen Access
Literature Highlights
The International Journal of Tuberculosis and Lung Disease·2023
Tuberculosis incidence in foreign-born people residing in European countries in 2020
Eurosurveillance·2023· 17 citedOpen Access
Cystic Fibrosis – results of CFTR modulators in Croatia
Liječnički vjesnik·2023Open Access
page 1 of 7Next →

Frequent Co-authors

Marko Jakopović(14), Miroslav Samaržija(14), Ljiljana Žmak(12), Stefano Aliberti(7), Mihaela Obrovac(7), Nora Morcillo(6), Giovanni Sotgiu(6), Jan Rupp(6), Milena Encheva(6), Marc Spielmanns(6), Ivan Sabol(6), Vera Katalinić Janković(6), Jakko van Ingen(5), Pedro J. Marcos(5), Patricia Aruj(5), Silvia Attorri(5), Enrique Barimboim(5), Juan Pablo Caeiro(5), María Isabel Garzón(5), Victor Hugo Cambursano(5)